A detailed history of Freestone Capital Holdings, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Freestone Capital Holdings, LLC holds 70,039 shares of MRK stock, worth $7.01 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares
70,039
Previous 66,795 4.86%
Holding current value
$7.01 Million
Previous $8.27 Million 3.82%
% of portfolio
0.27%
Previous 0.3%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$111.15 - $128.97 $360,570 - $418,378
3,244 Added 4.86%
70,039 $7.95 Million
Q2 2024

Nov 22, 2024

BUY
$123.8 - $132.96 $248,961 - $267,382
2,011 Added 3.1%
66,795 $8.27 Million
Q2 2024

Aug 13, 2024

BUY
$123.8 - $132.96 $248,961 - $267,382
2,011 Added 3.1%
66,795 $8.27 Million
Q1 2024

Nov 22, 2024

SELL
$113.24 - $131.95 $595,076 - $693,397
-5,255 Reduced 7.5%
64,784 $8.55 Million
Q1 2024

May 14, 2024

BUY
$113.24 - $131.95 $52,316 - $60,960
462 Added 0.72%
64,784 $8.55 Million
Q4 2023

Feb 13, 2024

BUY
$100.18 - $109.02 $82,648 - $89,941
825 Added 1.3%
64,322 $7.01 Million
Q3 2023

Nov 14, 2023

SELL
$102.95 - $114.33 $381,532 - $423,706
-3,706 Reduced 5.51%
63,497 $6.54 Million
Q2 2023

Aug 09, 2023

SELL
$108.61 - $118.38 $135,653 - $147,856
-1,249 Reduced 1.82%
67,203 $7.75 Million
Q1 2023

May 12, 2023

SELL
$102.94 - $114.86 $268,776 - $299,899
-2,611 Reduced 3.67%
68,452 $7.28 Million
Q4 2022

Feb 13, 2023

SELL
$87.44 - $112.11 $1.31 Million - $1.68 Million
-14,998 Reduced 17.43%
71,063 $7.88 Million
Q3 2022

Nov 09, 2022

SELL
$84.53 - $94.96 $1.67 Million - $1.88 Million
-19,783 Reduced 18.69%
86,061 $7.41 Million
Q2 2022

Aug 09, 2022

SELL
$83.49 - $94.64 $3.59 Million - $4.07 Million
-43,005 Reduced 28.89%
105,844 $9.65 Million
Q1 2022

May 12, 2022

SELL
$73.51 - $82.4 $1.8 Million - $2.02 Million
-24,475 Reduced 14.12%
148,849 $12.2 Million
Q4 2021

Feb 14, 2022

SELL
$72.28 - $90.54 $528,439 - $661,937
-7,311 Reduced 4.05%
173,324 $13.3 Million
Q3 2021

Nov 15, 2021

BUY
$71.68 - $78.83 $1.2 Million - $1.32 Million
16,749 Added 10.22%
180,635 $13.6 Million
Q2 2021

Aug 16, 2021

BUY
$70.31 - $77.77 $1.51 Million - $1.67 Million
21,421 Added 15.04%
163,886 $12.7 Million
Q1 2021

May 17, 2021

BUY
$68.86 - $81.11 $1.24 Million - $1.46 Million
18,053 Added 14.51%
142,465 $11 Million
Q4 2020

Feb 16, 2021

BUY
$71.77 - $79.65 $491,050 - $544,965
6,842 Added 5.82%
124,412 $10.2 Billion
Q3 2020

Nov 06, 2020

BUY
$73.18 - $82.95 $1.29 Million - $1.46 Million
17,651 Added 17.67%
117,570 $9.31 Million
Q2 2020

Aug 04, 2020

SELL
$70.42 - $80.13 $1.55 Million - $1.76 Million
-21,943 Reduced 18.01%
99,919 $7.73 Million
Q1 2020

May 12, 2020

BUY
$63.36 - $87.82 $3.23 Million - $4.48 Million
50,957 Added 71.87%
121,862 $9.38 Million
Q4 2019

Feb 04, 2020

BUY
$77.58 - $87.54 $3.21 Million - $3.63 Million
41,437 Added 140.62%
70,905 $6.45 Million
Q3 2019

Nov 07, 2019

BUY
$76.08 - $82.93 $435,025 - $474,193
5,718 Added 24.08%
29,468 $2.48 Million
Q2 2019

Aug 05, 2019

SELL
$69.84 - $81.59 $100,848 - $117,815
-1,444 Reduced 5.73%
23,750 $1.99 Million
Q1 2019

May 08, 2019

BUY
$69.58 - $79.36 $110,353 - $125,864
1,586 Added 6.72%
25,194 $2.1 Million
Q4 2018

Feb 12, 2019

BUY
$65.24 - $75.71 $33,402 - $38,763
512 Added 2.22%
23,608 $1.8 Million
Q3 2018

Nov 13, 2018

BUY
$57.69 - $67.84 $497,287 - $584,780
8,620 Added 59.55%
23,096 $1.64 Million
Q2 2018

Aug 14, 2018

BUY
$50.83 - $59.72 $24,042 - $28,247
473 Added 3.38%
14,476 $879,000
Q1 2018

May 15, 2018

BUY
$50.96 - $59.23 $240,989 - $280,098
4,729 Added 50.99%
14,003 $763,000
Q4 2017

Feb 13, 2018

BUY
$51.62 - $61.64 $3,613 - $4,314
70 Added 0.76%
9,274 $522,000
Q3 2017

Nov 14, 2017

BUY
$58.67 - $63.13 $3,989 - $4,292
68 Added 0.74%
9,204 $589,000
Q2 2017

Aug 15, 2017

BUY
N/A
9,136
9,136 $586,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $253B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Freestone Capital Holdings, LLC Portfolio

Follow Freestone Capital Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Freestone Capital Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Freestone Capital Holdings, LLC with notifications on news.